Use of multiparametric MRI to characterize uterine fibroid tissue types

[1]  Rajiv Chopra,et al.  Multiparametric MRI Characterization of Funaki Types of Uterine Fibroids Considered for MR-Guided High-Intensity Focused Ultrasound (MR-HIFU) Therapy. , 2019, Academic radiology.

[2]  Pierre-Marc Jodoin,et al.  Automatic classification of tissues on pelvic MRI based on relaxation times and support vector machine , 2019, PloS one.

[3]  G. Komar,et al.  Wedged gel pad for bowel manipulation during MR-guided high-intensity focused ultrasound therapy to treat uterine fibroids: a case report , 2018, Journal of therapeutic ultrasound.

[4]  Eleanor Martin,et al.  Experimental study of beam distortion due to fiducial markers during salvage HIFU in the prostate , 2018, Journal of therapeutic ultrasound.

[5]  E. Stewart,et al.  Epidemiology of uterine fibroids: a systematic review , 2017, BJOG : an international journal of obstetrics and gynaecology.

[6]  S. Lee,et al.  Scaled Signal Intensity of Uterine Fibroids on T2-Weighted MR Imaging as a Predictor of the Potential Response to Uterine Fibroid Embolization. , 2017, Journal of vascular and interventional radiology : JVIR.

[7]  Xiaoying Wang,et al.  The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China , 2016, Journal of therapeutic ultrasound.

[8]  I. Sohn,et al.  Screening Magnetic Resonance Imaging–Based Prediction Model for Assessing Immediate Therapeutic Response to Magnetic Resonance Imaging–Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids , 2016, Investigative Radiology.

[9]  W. Catherino,et al.  Uterine fibroids , 2016, Nature Reviews Disease Primers.

[10]  P. Schwartz,et al.  Review of Leiomyoma Variants. , 2015, AJR. American journal of roentgenology.

[11]  K. Nicolay,et al.  Multiparametric MRI analysis for the evaluation of MR‐guided high intensity focused ultrasound tumor treatment , 2015, NMR in biomedicine.

[12]  Irene Mindjuk MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single center , 2015, Journal of Therapeutic Ultrasound.

[13]  Hyun Park,et al.  Scaled signal intensity of uterine fibroids based on T2-weighted MR images: a potential objective method to determine the suitability for magnetic resonance-guided focused ultrasound surgery of uterine fibroids , 2015, European Radiology.

[14]  G. Pron Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis. , 2015, Ontario health technology assessment series.

[15]  Wen-zhi Chen,et al.  Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation. , 2015, Ultrasound in medicine & biology.

[16]  R. Stahl,et al.  MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre , 2015, European Radiology.

[17]  K. Vincken,et al.  Diffusion-weighted magnetic resonance imaging using different b-value combinations for the evaluation of treatment results after volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids , 2014, European Radiology.

[18]  B. Borah,et al.  The impact of uterine leiomyomas: a national survey of affected women. , 2013, American journal of obstetrics and gynecology.

[19]  Wen-Zhi Chen,et al.  Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. , 2013, European journal of radiology.

[20]  K. Coyne,et al.  Outcomes From Leiomyoma Therapies: Comparison With Normal Controls , 2010, Obstetrics and gynecology.

[21]  Sang Heum Kim,et al.  Contrast-Enhanced Dynamic MR Imaging of Uterine Fibroids as a Potential Predictor of Patient Eligibility for MR Guided Focused Ultrasound (MRgFUS) Treatment for Symptomatic Uterine Fibroids , 2010, Obstetrics and gynecology international.

[22]  R. Vanninen,et al.  Preinterventional quantitative magnetic resonance imaging predicts uterus and leiomyoma size reduction after uterine artery embolization , 2010, Journal of magnetic resonance imaging : JMRI.

[23]  K. Funaki,et al.  Clinical outcomes of magnetic resonance‐guided focused ultrasound surgery for uterine myomas: 24‐month follow‐up , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[24]  O. Kilickesmez,et al.  Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones , 2009, Acta radiologica.

[25]  Y. Na,et al.  Patient selection guidelines in MR-guided focused ultrasound surgery of uterine fibroids: a pictorial guide to relevant findings in screening pelvic MRI , 2008, European Radiology.

[26]  T. Hirai,et al.  Role of diffusion-weighted imaging in the diagnosis of gynecological diseases , 2008, European Radiology.

[27]  Y. Kaji,et al.  Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. , 2007, American journal of obstetrics and gynecology.

[28]  Kullervo Hynynen,et al.  MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. , 2003, Radiology.

[29]  K. Coyne,et al.  The UFS‐QOL, a New Disease‐Specific Symptom and Health‐Related Quality of Life Questionnaire for Leiomyomata , 2002, Obstetrics and gynecology.

[30]  E. Stewart Uterine fibroids , 2001, The Lancet.

[31]  D. Herbreteau,et al.  Arterial embolisation to treat uterine myomata , 1995, The Lancet.

[32]  A. Patel,et al.  The frequency of uterine leiomyomas. , 1990, American journal of clinical pathology.

[33]  E. Wallach,et al.  Uterine leiomyomata: etiology, symptomatology, and management. , 1981, Fertility and sterility.